View in EDS PDF Full Text

Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3.

Saved in:
Bibliographic Details
Title: Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3.
Authors: Hinterleitner M; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany., Pfeiffer R; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany., Trautwein NF; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany., Sipos B; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany., Singer S; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany., Nadalin S; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; Department of General and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany., Königsrainer A; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; Department of General and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany., Lauer UM; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Tuebingen, Germany., la Fougère C; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Tuebingen, Germany., Zender L; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Tuebingen, Germany., Hinterleitner C; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany.; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Jan 08; Vol. 14, pp. 1285529. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38260136
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hinterleitner+M%22">Hinterleitner M</searchLink>; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Pfeiffer+R%22">Pfeiffer R</searchLink>; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Trautwein+NF%22">Trautwein NF</searchLink>; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Sipos+B%22">Sipos B</searchLink>; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Singer+S%22">Singer S</searchLink>; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Nadalin+S%22">Nadalin S</searchLink>; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; Department of General and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Königsrainer+A%22">Königsrainer A</searchLink>; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; Department of General and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lauer+UM%22">Lauer UM</searchLink>; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22la+Fougère+C%22">la Fougère C</searchLink>; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany.; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Zender+L%22">Zender L</searchLink>; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hinterleitner+C%22">Hinterleitner C</searchLink>; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.; European Neuroendocrine Tumor Society (ENETS) Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany.; German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (iFIT), University of Tuebingen, Tuebingen, Germany.; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101555782%22">Frontiers in endocrinology</searchLink> [Front Endocrinol (Lausanne)] 2024 Jan 08; Vol. 14, pp. 1285529. <i>Date of Electronic Publication: </i>2024 Jan 08 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101555782 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2392 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642392%22">16642392 </searchLink><i>NLM ISO Abbreviation: </i>Front Endocrinol (Lausanne) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38260136
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fendo.2023.1285529
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1285529
    Titles:
      – TitleFull: Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hinterleitner M
      – PersonEntity:
          Name:
            NameFull: Pfeiffer R
      – PersonEntity:
          Name:
            NameFull: Trautwein NF
      – PersonEntity:
          Name:
            NameFull: Sipos B
      – PersonEntity:
          Name:
            NameFull: Singer S
      – PersonEntity:
          Name:
            NameFull: Nadalin S
      – PersonEntity:
          Name:
            NameFull: Königsrainer A
      – PersonEntity:
          Name:
            NameFull: Lauer UM
      – PersonEntity:
          Name:
            NameFull: la Fougère C
      – PersonEntity:
          Name:
            NameFull: Zender L
      – PersonEntity:
          Name:
            NameFull: Hinterleitner C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 01
              Text: 2024 Jan 08
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1664-2392
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in endocrinology
              Type: main
ResultId 1